MPM Oncology Impact Management GP LLC, 10% Owner at Harpoon Therapeutics, Inc. (HARP), sold 653,538 shares at $23.03 ($14.7M) on 2021-05-03, disclosed to the SEC on 2021-05-04.
Open-market sale of $14.7M HARP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.35 | 268,023 | $6.0M | 40.8% |
| 2 | $22.35 | 268,023 | $6.0M | 40.8% |
| 3 | $23.03 | 26,365 | $607K | 4.1% |
| 4 | $23.03 | 26,365 | $607K | 4.1% |
| 5 | $23.45 | 4,401 | $103K | 0.7% |
| 6 | $23.45 | 4,401 |
| $103K |
| 0.7% |
| 7 | $23.03 | 26,230 | $604K | 4.1% |
| 8 | $23.03 | 26,230 | $604K | 4.1% |
| 9 | $23.33 | 3,500 | $82K | 0.6% |
| Total | $22.48 avg | 653,538 | $14.7M | 100% |
| Filing → |
| HARP | SELL | 2021-05-20 | $2.0M | — | Filing → |
| HARP | SELL | 2021-05-17 | $520K | — | Filing → |
| HARP | SELL | 2021-04-22 | $330K | — | Filing → |